LL/2-luc Syngeneic Model

Synonyms: LL2-luciferase, LL/2-luciferase, LL2-luc, LL/2-luc, LL/2-luciferase-expressing cell line

LL/2-luc is a specialized cancer cell line derived from LL/2, engineered to express luciferase, an enzyme that emits light upon substrate addition. This unique feature enables non-invasive imaging of tumor growth and metastasis in real-time. LL/2-luc is particularly useful for imaging studies, allowing researchers to monitor the efficacy of therapeutic interventions and evaluate treatment response. With its luminescent properties, LL/2-luc provides valuable insights into lung cancer biology and facilitates the development of novel imaging-based approaches for studying tumor dynamics.

Model Details

Cancer Type: Lung Cancer
Model Name: LL/2-luc
Mouse Strain: C57BL/6
Treatment Data Available: aPD-1, aPD-L1, aCTLA-4

LL/2-luc Growth Curve: Response to aPD-1, aPD-L1, and aCTLA-4

Growth of subcutaneous LL/2-luc in C57BL/6 mice (n=8). Response to PD-1 dosed Q3D x 4, aPD-L1 dosed Q3D x 4, and aCTLA-4 dosed Q3D x 4.

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content